GSC
EW icon

Grey Street Capital’s Edwards Lifesciences EW Stock Holding History

Grey Street Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$233K Buy
+2,441
New +$205K 0.03% 441

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Grey Street Capital's EW Position: Q1 2024 in Review

Grey Street Capital opened a new position in Edwards Lifesciences (EW) in Q1 2024: 2,441 shares worth $233K. The stake represents 0.03% of the portfolio and ranks #441 among its holdings.

1,280 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Grey Street Capital held 2,441 shares of Edwards Lifesciences worth $233K as of Q1 2024.
  • Edwards Lifesciences was a new Grey Street Capital position in Q1 2024.
  • Edwards Lifesciences made up 0.03% of Grey Street Capital's portfolio in Q1 2024, its #441 holding.
  • 1,280 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.